Ran N. Zuo

Tianjin Key Laboratory Of Digestive Cancer
Tianjin, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Exploration and application of nanotechnology in precision transarterial chemoembolization for hepatocellular carcinoma

Exploration and application of nanotechnology in precision transarterial chemoembolization for hepatocellular carcinoma

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: April 09, 2026

FreeScene: Generative-enhanced visual modeling for generalized zero-shot image retrieval with scene sketches.

FreeScene: Generative-enhanced visual modeling for generalized zero-shot image retrieval with scene sketches.

Journal: Neural networks : the official journal of the International Neural Network Society
Published: January 30, 2026

Residual disease subtyping predicts survival and guides adjuvant immunotherapy in esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy.

Residual disease subtyping predicts survival and guides adjuvant immunotherapy in esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy.

Journal: Frontiers in immunology
Published: November 08, 2025

cPLA2α inhibition potentiates anti-PD-1 immunotherapy in lung adenocarcinoma via remodeling tumor microenvironment.

cPLA2α inhibition potentiates anti-PD-1 immunotherapy in lung adenocarcinoma via remodeling tumor microenvironment.

Journal: Communications biology
Published: July 25, 2025

STK11/KEAP1 co-mutations in SMARCA4-mutant advanced non-small cell lung cancer: genetic characteristics and impact on immunotherapy efficacy.

STK11/KEAP1 co-mutations in SMARCA4-mutant advanced non-small cell lung cancer: genetic characteristics and impact on immunotherapy efficacy.

Journal: Translational lung cancer research
Published: March 16, 2025

5-HT regulates resistance to aumolertinib by attenuating ferroptosis in lung adenocarcinoma.

5-HT regulates resistance to aumolertinib by attenuating ferroptosis in lung adenocarcinoma.

Journal: EMBO molecular medicine
Published: March 05, 2025

Trilaciclib triggers a neutrophil-related immune response and sensitizes non-small cell lung cancer to anti-PD-1 therapy.

Trilaciclib triggers a neutrophil-related immune response and sensitizes non-small cell lung cancer to anti-PD-1 therapy.

Journal: Cell reports. Medicine
Published: February 21, 2025

Immune-related gene risk model establishment and role of key gene FUCA1 in malignant pleural mesothelioma.

Immune-related gene risk model establishment and role of key gene FUCA1 in malignant pleural mesothelioma.

Journal: Frontiers in pharmacology
Published: February 15, 2025

CCDC34 maintains stemness phenotype through β-catenin-mediated autophagy and promotes EGFR-TKI resistance in lung adenocarcinoma.

CCDC34 maintains stemness phenotype through β-catenin-mediated autophagy and promotes EGFR-TKI resistance in lung adenocarcinoma.

Journal: Cancer gene therapy
Published: March 06, 2024

PD-L1 induces autophagy and primary resistance to EGFR-TKIs in EGFR-mutant lung adenocarcinoma via the MAPK signaling pathway.

PD-L1 induces autophagy and primary resistance to EGFR-TKIs in EGFR-mutant lung adenocarcinoma via the MAPK signaling pathway.

Journal: Cell death & disease
Published: January 28, 2024

OVOL2 induces autophagy-mediated epithelial-mesenchymal transition by the ERK1/2 MAPK signaling in lung adenocarcinoma.

OVOL2 induces autophagy-mediated epithelial-mesenchymal transition by the ERK1/2 MAPK signaling in lung adenocarcinoma.

Journal: iScience
Published: August 11, 2023

The response prediction and prognostic values of systemic inflammation response index in patients with advanced lung adenocarcinoma.

The response prediction and prognostic values of systemic inflammation response index in patients with advanced lung adenocarcinoma.

Journal: Thoracic cancer
Published: January 29, 2023
Showing 1-12 of 29

Last Updated: 09/26/2026